Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medtronic PLC (MDT : NYSE)
 
 • Company Description   
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Number of Employees: 95,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $83.21 Daily Weekly Monthly
20 Day Moving Average: 7,543,103 shares
Shares Outstanding: 1,280.05 (millions)
Market Capitalization: $106,512.55 (millions)
Beta: 0.56
52 Week High: $106.33
52 Week Low: $73.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.34% 2.58%
12 Week 2.77% -0.05%
Year To Date -13.38% -21.11%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING TWO PARKMORE BUSINESS PARK WEST
-
GALWAY,L2 H91
IRL		 ph: 353-1438-1700
fax: 763-514-4879		 investor.relations@medtronic.com http://www.medtronic.com
 
 • General Corporate Information   
Officers
Geoffrey S. Martha - Chairman and Chief Executive Officer
Thierry Pieton - Executive Vice President and Chief Financial Offic
Denise L. Blomquist - Vice President and Chief Accounting Officer
Michelle Quinn - Executive Vice President; General Counsel and Secr
Craig Arnold - Director

Peer Information
Medtronic PLC (BJCT)
Medtronic PLC (CADMQ)
Medtronic PLC (APNO)
Medtronic PLC (UPDC)
Medtronic PLC (IMTIQ)
Medtronic PLC (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G5960L103
SIC: 3845
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 04/01/26
Next Expected EPS Date: 09/01/26
Share - Related Items
Shares Outstanding: 1,280.05
Most Recent Split Date: 9.00 (2.00:1)
Beta: 0.56
Market Capitalization: $106,512.55 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.46%
Current Fiscal Quarter EPS Consensus Estimate: $1.38 Indicated Annual Dividend: $2.88
Current Fiscal Year EPS Consensus Estimate: $5.94 Payout Ratio: 0.51
Number of Estimates in the Fiscal Year Consensus: 12.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 6.28% Last Dividend Paid: 06/26/2026 - $0.72
Next EPS Report Date: 09/01/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 14.00
Trailing 12 Months: 15.05
PEG Ratio: 2.23
Price Ratios
Price/Book: 2.13
Price/Cash Flow: 10.60
Price / Sales: 2.93
EPS Growth
vs. Year Ago Period: -4.32%
vs. Previous Quarter: 13.97%
Sales Growth
vs. Year Ago Period: 9.86%
vs. Previous Quarter: 8.76%
ROE
04/30/26 - 14.51
01/31/26 - 14.82
10/31/25 - 14.86
ROA
04/30/26 - 7.76
01/31/26 - 7.88
10/31/25 - 7.96
Current Ratio
04/30/26 - 2.13
01/31/26 - 2.54
10/31/25 - 2.42
Quick Ratio
04/30/26 - 1.62
01/31/26 - 1.87
10/31/25 - 1.80
Operating Margin
04/30/26 - 19.58
01/31/26 - 20.30
10/31/25 - 20.83
Net Margin
04/30/26 - 13.20
01/31/26 - 13.00
10/31/25 - 13.71
Pre-Tax Margin
04/30/26 - 16.87
01/31/26 - 15.68
10/31/25 - 16.40
Book Value
04/30/26 - 39.00
01/31/26 - 38.32
10/31/25 - 38.11
Inventory Turnover
04/30/26 - 2.09
01/31/26 - 2.09
10/31/25 - 2.07
Debt-to-Equity
04/30/26 - 0.52
01/31/26 - 0.57
10/31/25 - 0.57
Debt-to-Capital
04/30/26 - 34.33
01/31/26 - 36.17
10/31/25 - 36.17
 

Powered by Zacks Investment Research ©